FIELD: medicine; endocrinology.
SUBSTANCE: fat content control in the organism is ensured by stabilisation of alpha subunit of hypoxia induced factor protein (HIFα). To stabilise HIFα, effective amount of compound, inhibiting HIF hydroxylase activity, is introduced.
EFFECT: reduced lipogenesis and lipopexia ensured with fat metabolism control.
23 cl, 11 dwg, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FAT CONTENT REGULATION | 2008 |
|
RU2397766C2 |
| APPLICATION OF STABILISERS OF HIF- ALPHA FOR INTENSIFICATION OF ERYTHROPOIESIS | 2004 |
|
RU2414214C2 |
| DIABETES TREATMENT | 2003 |
|
RU2363465C2 |
| REGULATION OF METABOLISM USING MIR-378 | 2011 |
|
RU2585491C2 |
| COMPOSITION FOR PREVENTING, IMPROVING OR TREATING OBESITY OR FATTY LIVER DISEASE CONTAINING LEUCONOSTOC CITREUM WiKim0104 | 2020 |
|
RU2816754C2 |
| METHOD OF INHIBITING SUCTION AND/OR INCREASING LIPID RELEASE WITH USING D-PSICOSE | 2016 |
|
RU2725145C2 |
| TREATMENT OF LIVER, BILE DUCT AND PANCREATIC DISORDERS | 2017 |
|
RU2740913C2 |
| METHOD OF TREATMENT OF PATHOLOGICAL DEVIATIONS AT DIABETES MELLITUS OF TYPE-2 | 1992 |
|
RU2104698C1 |
| METHOD FOR LEAN MUSCLE MASS GAIN AND FATTY TISSUE REDUCTION | 2007 |
|
RU2456985C2 |
| STRAIN OF AKKERMANSIA MUCINIPHILA AND APPLICATION THEREOF | 2019 |
|
RU2777068C1 |
